Bloomberg BNA's Health IT Law & Industry Report brings you concise, comprehensive, and timely news and analysis of the regulatory, legal, and compliance issues surrounding our nation’s...
Industry Comments on Proposed Stage 2 Meaningful Use Criteria
Key Take Away:Proposed Stage 2 criteria may be too difficult for hospitals and providers to achieve.
Recommendations:CMS should change the Stage 2 time frame, simplify Stage 2 objectives, and align clinical quality measures to make the criteria feasible.
Elements of proposed “meaningful use” criteria for Stage 2 of the Medicare and Medicaid electronic health record incentive programs could be too difficult for hospitals, the American Hospital Association said in comments submitted May 1 to the Centers for Medicare & Medicaid Services.
According to a letter from the association, the Stage 2 objectives to achieve meaningful use of EHRs could “stand in the way of a successful program to support widespread adoption by all hospitals” of EHR systems.
AHA expressed “major concerns” with parts of the proposed criteria related to:
• implementation of the Medicare penalty phase;
• proposed timing and staging of the next phase of the incentive program;
• specific objectives and measures for Stage 2; and
• reporting of clinical quality measures through EHRs.
Many of the proposals for Stage 2 of the program “put regulatory requirements ahead of actual experience with these technologies,” an approach that would likely be a barrier to adoption, AHA said.
AHA and the College of Healthcare Information Management Executives (CHIME) recommended that CMS establish a 90-day reporting period for Stage 2 that mirrors the reporting period for Stage 1 of the EHR incentive programs.
AHA also recommended that each stage of the meaningful use programs last three years to ensure vendors and providers have adequate time to transition safely and without “undue distortions to the market.”
“We felt the approach taken in Stage 1 gave providers much-needed time to make sure the correct fields were populating and accurate meaningful use reports were being produced--we think a similar approach is needed for Stage 2 and beyond,” Pam McNutt, CHIME member and senior vice president and chief information officer at Dallas-based Methodist health System, said in a release.
CMS released the proposed Stage 2 meaningful use criteria Feb. 23, and they were published in the March 7 Federal Register (77 Fed. Reg. 13,698, March 7, 2012)(see previous article). The AHA and CHIME letters were sent as public comments on the proposed rule. The public comment deadline is May 7.
According to AHA, taken as a whole, the proposed requirements for meeting Stage 2 “raise the bar too high” and are not feasible for the majority of hospitals to achieve.
AHA recommended that CMS make Stage 2 objectives more feasible and less burdensome for both hospitals and eligible professionals by:
• preserving the existing approach of a core (mandatory) set of required objectives accompanied by a menu (optional) set with limited choice among objectives;
• introducing all new objectives through the menu set;
• moving menu items to the core at the same performance threshold set in Stage 1; and
• removing measures that make the performance of hospitals and eligible professionals contingent on the actions of others.
For example, proposed criteria that rely on patient-initiated access of their health data are not feasible as proposed, raise significant security issues, and go beyond current technical capacity, according to the comments.
Comments from CHIME urged CMS to expand the menu set options for the proposed Stage 2 criteria, so that eligible professionals and hospitals have flexibility in achieving meaningful use of EHRs.
“The menu set for both EPs and hospitals is quite small in relation to the minimum number that would need to be met, thereby providing relatively few options for EPs and hospitals,” CHIME said.
Overall, CHIME said the accurate reporting of clinical quality measures was one of the “the most daunting challenges faced by providers today.”
While EHR products have the ability to automatically produce CQM reports, the data are often inaccurate and cannot be shared across different providers or care settings, according to the comments.
In comments to the Office of the National Coordinator for Health Information Technology on standards and certification criteria for 2014, CHIME recommended that part of the EHR certification process include certification of all CQMs needed to meet meaningful use in each care setting.
Additionally, CHIME offered to work with ONC to minimize the costs of development and implementation by limiting the total number of CQMs associated with each care setting.
ONC published a companion proposal in the March 7 Federal Register (77 Fed. Reg. 13,832, March 7, 2012) outlining the EHR standards, certification criteria, and implementation specifications needed to participate in the incentive programs starting in 2014 (see previous article).
In its letter to CMS, AHA “strongly urged” the agency to defer adding new hospital clinical quality measures to the meaningful use program until Stage 3, so that Stage 2 could be used to make the process accurate and aligned across multiple federal quality improvement programs.
The AHA comments are available at http://www.aha.org/advocacy-issues/letter/2012/120430-cl-cms0044p.pdf.
The CHIME comments to CMS are available at http://www.cio-chime.org/advocacy/resources/download/CHIME_Comments-Electronic_Health_Record_Incentive_Program-Stage_2_NPRM.pdf.
The CHIME comments to ONC are available at http://www.cio-chime.org/advocacy/resources/download/CHIME_Comments-2014_Edition_EHR_Standards_and_Certification_Criteria_NPRM.pdf.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)